Friday, 10 May 2013

Cameroon Pharmaceuticals and Healthcare Report Q3 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
May 8th 2013, 00:00

BMI View: Despite the strong growth potential of its pharmaceutical market, we believe Cameroon isunlikely to be of significant interest to multinational pharmaceutical firms. The country''s shortcomingsinclude poor public health provision and rampant corruption. Consequently we project that the fullpotential of the pharmaceutical sector will only be seen if major improvements are made to Cameroon''seconomy and government contributions to healthcare.Headline Expenditure Projections? Pharmaceuticals: XAF134.81bn (US$260mn) in 2012 to XAF153.17bn (US$310mn) in 2013; +13.6%in local currency terms and +20.3% in US dollar terms. Forecast upgraded from Q213, following<...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment